(2R)-1-[4-(4-chlorocyclohexa-1,3-dien-1-yl)-3,3-dimethylpiperidin-1-yl]-N-ethyl-3-methylbutan-2-amine
C20H35ClN2 — CID 58457820
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2R)-1-[4-(4-chlorocyclohexa-1,3-dien-1-yl)-3,3-dimethylpiperidin-1-yl]-N-ethyl-3-methylbutan-2-amine
(2R)-1-[4-(4-chlorocyclohexa-1,3-dien-1-yl)-3,3-dimethylpiperidin-1-yl]-N-ethyl-3-methylbutan-2-amine (PubChem CID 58457820) has the molecular formula C20H35ClN2 and a molecular weight of 338.97 g/mol. Its IUPAC name is (2R)-1-[4-(4-chlorocyclohexa-1,3-dien-1-yl)-3,3-dimethylpiperidin-1-yl]-N-ethyl-3-methylbutan-2-amine.
Molecular Properties
| Compound Name | (2R)-1-[4-(4-chlorocyclohexa-1,3-dien-1-yl)-3,3-dimethylpiperidin-1-yl]-N-ethyl-3-methylbutan-2-amine |
|---|---|
| PubChem CID | 58457820 |
| Molecular Formula | C20H35ClN2 |
| Molecular Weight | 338.97 g/mol |
| Exact Mass | 338.25 |
| IUPAC Name | (2R)-1-[4-(4-chlorocyclohexa-1,3-dien-1-yl)-3,3-dimethylpiperidin-1-yl]-N-ethyl-3-methylbutan-2-amine |
| SMILES | CCN[C@@H](CN1CCC(C2=CC=C(Cl)CC2)C(C)(C)C1)C(C)C |
| InChI | InChI=1S/C20H35ClN2/c1-6-22-19(15(2)3)13-23-12-11-18(20(4,5)14-23)16-7-9-17(21)10-8-16/h7,9,15,18-19,22H,6,8,10-14H2,1-5H3/t18?,19-/m0/s1 |
| InChIKey | ZZYBBQBWDANDPA-GGYWPGCISA-N |
| XLogP | 4.81 |
| TPSA | 15.27 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 23 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 338.97 |
| LogP ≤ 5 | 4.81 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 2 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 58457820 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.